出血性疾患検査の世界市場レポート 2025年

出血性疾患検査市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.9％で220億2,000万米ドルに成長します。予測期間の成長は、血友病の有病率の増加、出血性疾患の症状に対する認知度の上昇、診断調査への投資の増加、世界のヘルスケア支出の増加、希少出血性疾患の有病率の上昇に起因すると考えられます。予測期間における主な動向としては、技術の進歩、人工知能の統合、個別化医療、遠隔医療サービス、在宅検査キットなどが挙げられます。

臨床試験の増加は、今後数年間の出血性疾患検査市場の成長を後押しすると予想されます。臨床試験とは、ヒトを対象とした新しい治療、治療法、医薬品、技術の安全性と有効性を評価する調査であり、増加傾向にあります。この増加の背景には、医学研究の進歩、ヘルスケアイノベーションへの投資の増加、新しい治療法や治療法に対する需要の高まりがあります。このような臨床試験において、出血性疾患検査は出血性疾患に対する新薬や治療法の有効性と安全性を評価し、凝固異常を管理または修正する能力を評価し、最適な投与量と有効性を確保するために患者の反応をモニタリングするために極めて重要です。例えば、米国の臨床試験登録機関であるClinicalTrials.govによると、2023年末までに約47万7,228件の臨床試験が登録され、2022年の43万7,507件から増加しています。このように、臨床試験数の増加が出血性疾患検査市場の拡大を後押ししています。

出血性疾患検査市場の主要企業は、長期的な解決策を提供し、遺伝性出血性疾患を治癒させ、治療成績を向上させ、市場でのプレゼンスを拡大するために、血友病Bの遺伝子治療などの革新的な製品の開発に注力しています。血友病Bは、適切な血液凝固に必要な血液凝固第IX因子の欠乏を特徴とする出血性疾患の一種です。血友病Bの遺伝子治療は、症状の原因となっている根本的な遺伝的欠陥に対処することで、長期的な解決を目指す新たな治療法です。例えば、2023年2月、オーストラリアを拠点とするバイオテクノロジー企業であるCSLリミテッドは、重度および中等度の血友病Bを治療するための最初で唯一の1回限りの遺伝子治療であるHEMGENIXについて、欧州委員会から条件付き販売承認（CMA）を取得しました。この革新的な治療は、長期にわたる有効性を提供することを目的としており、定期的な因子補充療法の必要性を低減または排除し、血友病B患者の標準治療を大きく変える可能性があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界出血性疾患検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の出血性疾患検査市場：成長率分析
• 世界の出血性疾患検査市場の実績：規模と成長, 2019-2024
• 世界の出血性疾患検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界出血性疾患検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の出血性疾患検査市場：製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 試薬および消耗品
• 機器
• 世界の出血性疾患検査市場適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血友病A
• 血友病B
• フォン・ヴィレブランド病
• 特発性血小板減少性紫斑病
• その他の適応症
• 世界の出血性疾患検査市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 因子補充療法
• 薬物療法
• 世界の出血性疾患検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院と診療所
• 診断センター
• その他のエンドユーザー
• 世界の出血性疾患検査市場試薬および消耗品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 凝固試薬
• 血漿および血液採取用消耗品
• 止血試薬
• 因子欠乏検査キット
• 活性化部分トロンボプラスチン時間（APTT）試薬
• 世界の出血性疾患検査市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 凝固分析装置
• 血小板機能分析装置
• 止血検査機器
• ポイントオブケア検査装置
• 自動血液検査システム

第7章 地域別・国別分析

• 世界の出血性疾患検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の出血性疾患検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 出血性疾患検査市場：競合情勢
• 出血性疾患検査市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Siemens Healthcare GmbH
• Baxter International Inc.
• CSL Limited
• Octapharma AG
• HORIBA Ltd.
• Haemonetics Corporation
• Diagnostica Stago S.A.S.
• Sekisui Diagnostics LLC
• Helena Laboratories Corporation
• LFB Group
• Sysmex Inostics GmbH
• Medexus Pharmaceuticals Inc.
• Precision Biologics Inc.
• Corgenix Inc.
• Diapharma Group Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 出血性疾患検査市場2029：新たな機会を提供する国
• 出血性疾患検査市場2029：新たな機会を提供するセグメント
• 出血性疾患検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Bleeding disorder testing encompasses a variety of diagnostic methods aimed at assessing the function and composition of blood to detect abnormalities associated with bleeding disorders. These tests evaluate clotting ability, platelet function, and specific deficiencies or dysfunctions of clotting factors.

The primary product categories for bleeding disorder testing are reagents and consumables, as well as instruments. The reagents and consumables segment includes the chemical substances, materials, and disposable items utilized in the diagnosis and analysis of bleeding disorders. This category features test kits, reagents, and other necessary supplies for performing these tests. Common indications for these tests include hemophilia A, hemophilia B, von Willebrand disease, idiopathic thrombocytopenic purpura, among others. Treatments generally involve factor replacement therapy and drug therapy, and the tests are used by various end-users, such as hospitals, clinics, and diagnostic centers.

The bleeding disorder testing market research report is one of a series of new reports from The Business Research Company that provides bleeding disorder testing market statistics, including bleeding disorder testing industry global market size, regional shares, competitors with a bleeding disorder testing market share, detailed bleeding disorder testing market segments, market trends, and opportunities, and any further data you may need to thrive in the bleeding disorder testing industry. This bleeding disorder testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bleeding disorder testing market size has grown strongly in recent years. It will grow from $14.99 billion in 2024 to $16.23 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to the increasing prevalence of bleeding disorders, increasing investment in research and development, a growing number of specialized clinics, increasing demand for early diagnosis, and a rising number of clinical trials.

The bleeding disorder testing market size is expected to see strong growth in the next few years. It will grow to $22.02 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to the increasing prevalence of hemophilia rising awareness of bleeding disorder symptoms, increasing investment in diagnostic research, rising healthcare spending globally, and rising prevalence of rare bleeding disorders. Major trends in the forecast period include technological advancements, integration of artificial intelligence, personalized medicine, telemedicine services, and home-based testing kits.

The increasing number of clinical trials is anticipated to boost the growth of the bleeding disorder testing market in the coming years. Clinical trials, which are research studies that evaluate the safety and effectiveness of new medical treatments, therapies, medicines, or technologies in humans, are on the rise. This increase is driven by advancements in medical research, growing investment in healthcare innovation, and the rising demand for new treatments and therapies. In these trials, bleeding disorder testing is crucial for assessing the efficacy and safety of new medicines and therapies for bleeding disorders, evaluating their ability to manage or correct clotting abnormalities, and monitoring patient responses to ensure optimal dosing and effectiveness. For example, according to ClinicalTrials.gov, a US-based clinical trial registry, approximately 477,228 clinical trials were registered by the end of 2023, up from 437,507 in 2022. Thus, the growing number of clinical trials is propelling the bleeding disorder testing market's expansion.

Leading companies in the bleeding disorder testing market are focusing on developing innovative products, such as gene therapy for Hemophilia B, to provide long-term solutions, cure genetic bleeding disorders, improve treatment outcomes, and broaden their market presence. Hemophilia B, characterized by a deficiency of clotting factor IX necessary for proper blood coagulation, is a specific type of bleeding disorder. Gene therapy for Hemophilia B is an emerging treatment that aims to offer a long-term solution by addressing the underlying genetic defect causing the condition. For instance, in February 2023, CSL Limited, an Australia-based biotechnology company, received conditional marketing authorization (CMA) from the European Commission for HEMGENIX, the first and only one-time gene therapy for treating severe and moderately severe Hemophilia B. This innovative treatment aims to provide long-lasting efficacy, potentially reducing or eliminating the need for regular factor replacement therapy and significantly altering the standard of care for Hemophilia B patients.

In May 2022, Sema4, a US-based company specializing in genetic testing and data-driven patient insights, acquired GeneDx, LLC for $150 million. This acquisition aims to enhance Sema4's genetic testing capabilities by integrating GeneDx's expertise in genetic diagnostics for rare and inherited disorders, including bleeding disorders. GeneDx LLC, also based in the US, offers testing related to bleeding disorders as part of its comprehensive genetic diagnostic services.

Major companies operating in the bleeding disorder testing market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Siemens Healthcare GmbH, Baxter International Inc., CSL Limited, Octapharma AG, HORIBA Ltd., Haemonetics Corporation, Diagnostica Stago S.A.S., Sekisui Diagnostics LLC, Helena Laboratories Corporation, LFB Group, Sysmex Inostics GmbH, Medexus Pharmaceuticals Inc., Precision Biologics Inc., Corgenix Inc., Diapharma Group Inc., Hyphen BioMed, Hema Biologics LLC

North America was the largest region in the bleeding disorder testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bleeding disorder testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bleeding disorder testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bleeding disorder testing market consists of revenues earned by entities by providing services such as complete blood count (CBC), prothrombin time (PT), activated partial thromboplastin time (aPTT), and genetic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The bleeding disorder testing market also includes sales of coagulation analyzers, platelet aggregation analyzers, blood collection devices, genetic testing kits, and bleeding time test kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bleeding Disorder Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bleeding disorder testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bleeding disorder testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bleeding disorder testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Reagents And Consumables; Instruments
• 2) By Indication: Hemophilia A; Hemophilia B; Von Willebrand Disease; Idiopathic Thrombocytopenic Purpura; Other Indications
• 3) By Treatment Type: Factor Replacement Therapy; Drug Therapy
• 4) By End User: Hospitals And Clinics; Diagnostic Centers; Other End Users
• Subsegments:
• 1) By Reagents And Consumables: Coagulation Reagents; Plasma And Blood Collection Consumables; Hemostasis Reagents; Factor Deficiency Assay Kits; Activated Partial Thromboplastin Time (APTT) Reagents
• 2) By Instruments: Coagulation Analyzers; Platelet Function Analyzers; Hemostasis Testing Instruments; Point-Of-Care Testing Devices; Automated Blood Testing Systems
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited; Novo Nordisk A/S
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bleeding Disorder Testing Market Characteristics

3. Bleeding Disorder Testing Market Trends And Strategies

4. Bleeding Disorder Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Bleeding Disorder Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bleeding Disorder Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bleeding Disorder Testing Market Growth Rate Analysis
• 5.4. Global Bleeding Disorder Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bleeding Disorder Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bleeding Disorder Testing Total Addressable Market (TAM)

6. Bleeding Disorder Testing Market Segmentation

• 6.1. Global Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Consumables
• Instruments
• 6.2. Global Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hemophilia A
• Hemophilia B
• Von Willebrand Disease
• Idiopathic Thrombocytopenic Purpura
• Other Indications
• 6.3. Global Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Factor Replacement Therapy
• Drug Therapy
• 6.4. Global Bleeding Disorder Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Centers
• Other End Users
• 6.5. Global Bleeding Disorder Testing Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coagulation Reagents
• Plasma And Blood Collection Consumables
• Hemostasis Reagents
• Factor Deficiency Assay Kits
• Activated Partial Thromboplastin Time (APTT) Reagents
• 6.6. Global Bleeding Disorder Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coagulation Analyzers
• Platelet Function Analyzers
• Hemostasis Testing Instruments
• Point-Of-Care Testing Devices
• Automated Blood Testing Systems

7. Bleeding Disorder Testing Market Regional And Country Analysis

• 7.1. Global Bleeding Disorder Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bleeding Disorder Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bleeding Disorder Testing Market

• 8.1. Asia-Pacific Bleeding Disorder Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bleeding Disorder Testing Market

• 9.1. China Bleeding Disorder Testing Market Overview
• 9.2. China Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bleeding Disorder Testing Market

• 10.1. India Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bleeding Disorder Testing Market

• 11.1. Japan Bleeding Disorder Testing Market Overview
• 11.2. Japan Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bleeding Disorder Testing Market

• 12.1. Australia Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bleeding Disorder Testing Market

• 13.1. Indonesia Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bleeding Disorder Testing Market

• 14.1. South Korea Bleeding Disorder Testing Market Overview
• 14.2. South Korea Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bleeding Disorder Testing Market

• 15.1. Western Europe Bleeding Disorder Testing Market Overview
• 15.2. Western Europe Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bleeding Disorder Testing Market

• 16.1. UK Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bleeding Disorder Testing Market

• 17.1. Germany Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bleeding Disorder Testing Market

• 18.1. France Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bleeding Disorder Testing Market

• 19.1. Italy Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bleeding Disorder Testing Market

• 20.1. Spain Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bleeding Disorder Testing Market

• 21.1. Eastern Europe Bleeding Disorder Testing Market Overview
• 21.2. Eastern Europe Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bleeding Disorder Testing Market

• 22.1. Russia Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bleeding Disorder Testing Market

• 23.1. North America Bleeding Disorder Testing Market Overview
• 23.2. North America Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bleeding Disorder Testing Market

• 24.1. USA Bleeding Disorder Testing Market Overview
• 24.2. USA Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bleeding Disorder Testing Market

• 25.1. Canada Bleeding Disorder Testing Market Overview
• 25.2. Canada Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bleeding Disorder Testing Market

• 26.1. South America Bleeding Disorder Testing Market Overview
• 26.2. South America Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bleeding Disorder Testing Market

• 27.1. Brazil Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bleeding Disorder Testing Market

• 28.1. Middle East Bleeding Disorder Testing Market Overview
• 28.2. Middle East Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bleeding Disorder Testing Market

• 29.1. Africa Bleeding Disorder Testing Market Overview
• 29.2. Africa Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bleeding Disorder Testing Market Competitive Landscape And Company Profiles

• 30.1. Bleeding Disorder Testing Market Competitive Landscape
• 30.2. Bleeding Disorder Testing Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis

31. Bleeding Disorder Testing Market Other Major And Innovative Companies

• 31.1. Siemens Healthcare GmbH
• 31.2. Baxter International Inc.
• 31.3. CSL Limited
• 31.4. Octapharma AG
• 31.5. HORIBA Ltd.
• 31.6. Haemonetics Corporation
• 31.7. Diagnostica Stago S.A.S.
• 31.8. Sekisui Diagnostics LLC
• 31.9. Helena Laboratories Corporation
• 31.10. LFB Group
• 31.11. Sysmex Inostics GmbH
• 31.12. Medexus Pharmaceuticals Inc.
• 31.13. Precision Biologics Inc.
• 31.14. Corgenix Inc.
• 31.15. Diapharma Group Inc.

32. Global Bleeding Disorder Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bleeding Disorder Testing Market

34. Recent Developments In The Bleeding Disorder Testing Market

35. Bleeding Disorder Testing Market High Potential Countries, Segments and Strategies

• 35.1 Bleeding Disorder Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bleeding Disorder Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bleeding Disorder Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer